{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T03:38:12Z","timestamp":1791171492484,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.jaci.2006.05.031","type":"journal-article","created":{"date-parts":[[2006,9,27]],"date-time":"2006-09-27T07:30:07Z","timestamp":1159342207000},"page":"1133-1141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":381,"title":["Nasal IL-5 levels determine the response to anti\u2013IL-5 treatment in patients with nasal polyps"],"prefix":"10.1016","volume":"118","author":[{"given":"Philippe","family":"Gevaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Lang-Loidolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Stammberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Van Zele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Holtappels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van Cauwenberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2006.05.031_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2500\/105065800781329573","article-title":"Nasal polyposis: from cytokines to growth","volume":"14","author":"Bachert","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2006.05.031_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-6749(77)90171-3","article-title":"Nasal polyps in asthma and rhinitis. A review of 6,037 patients","volume":"59","author":"Settipane","year":"1977","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000053724","article-title":"Regulation of IL-5 receptor on eosinophil progenitors in allergic inflammation: role of retinoic acid","volume":"124","author":"Denburg","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib4","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2006.05.031_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0091-6749(97)80019-X","article-title":"IL-5 synthesis is upregulated in human nasal polyp tissue","volume":"99","author":"Bachert","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1034\/j.1398-9995.2003.00110.x","article-title":"Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis","volume":"58","author":"Gevaert","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2006.05.031_bib7","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.158.8.3902","article-title":"Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia","volume":"158","author":"Simon","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/rr41","article-title":"Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease","volume":"2","author":"Greenfeder","year":"2001","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2006.05.031_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1172\/JCI17974","article-title":"Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics","volume":"112","author":"Flood-Page","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaci.2006.05.031_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","article-title":"Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway","volume":"167","author":"Flood-Page","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.05.031_bib11","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","article-title":"Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response","volume":"356","author":"Leckie","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2006.05.031_bib12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1164\/rccm.200206-525OC","article-title":"Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study","volume":"167","author":"Kips","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2006.05.031_bib13","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1182\/blood-2003-10-3620","article-title":"Safety and efficacy of the monoclonal anti-interleukin 5 antibody, SCH55700, in the treatment of patients with the hypereosinophilic syndrome","volume":"103","author":"Klion","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2006.05.031_bib14","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1056\/NEJMoa031261","article-title":"Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis","volume":"349","author":"Plotz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2006.05.031_bib15","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.4049\/jimmunol.169.11.6459","article-title":"Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process","volume":"169","author":"Liu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib16","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.4049\/jimmunol.169.11.6452","article-title":"Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 Receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge","volume":"169","author":"Liu","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1471-4914(02)02302-X","article-title":"Interleukin-5 and eosinophils as therapeutic targets for asthma","volume":"8","author":"Foster","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2006.05.031_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.183.1.195","article-title":"Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model","volume":"183","author":"Foster","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2006.05.031_bib19","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.4049\/jimmunol.164.4.2142","article-title":"The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity","volume":"164","author":"Mould","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2222.2000.00772.x","article-title":"Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness","volume":"30","author":"Tournoy","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2006.05.031_bib21","doi-asserted-by":"crossref","first-page":"6982","DOI":"10.4049\/jimmunol.166.11.6982","article-title":"The allergen-induced airway hyperresponsiveness in a human-mouse chimera model of asthma is T cell and IL-4 and IL-5 dependent","volume":"166","author":"Tournoy","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib22","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.170.11.5359","volume":"170","author":"Gregory","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaci.2006.05.031_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1084\/jem.175.2.341","article-title":"Molecular cloning and expression of the human interleukin 5 receptor","volume":"175","author":"Murata","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2006.05.031_bib24","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1073\/pnas.89.15.7041","article-title":"Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit","volume":"89","author":"Tavernier","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2006.05.031_bib25","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.92.11.5194","article-title":"Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist","volume":"92","author":"Tavernier","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2006.05.031_bib26","first-page":"451","article-title":"Organization and chromosomal localization of the human interleukin 5 receptor alpha-chain gene","volume":"3","author":"Tuypens","year":"1992","journal-title":"Eur Cytokine Netw"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906015739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674906015739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:06:12Z","timestamp":1758776772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674906015739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0091674906015739"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2006.05.031","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nasal IL-5 levels determine the response to anti\u2013IL-5 treatment in patients with nasal polyps","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2006.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Allergy, Asthma and Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}